A9543TC — Y90 Ibritumomab, Rx
Cite this view
HANK Price Transparency. (n.d.). Y90 ibritumomab, rx (OTHER A9543TC) negotiated rates. PPMan price-transparency data, derived from CMS-required hospital MRFs. Retrieved , from http://ppman.hank.ai/transparency/code/A9543TC?code_type=OTHER
“Y90 ibritumomab, rx (OTHER A9543TC) negotiated rates.” HANK Price Transparency, http://ppman.hank.ai/transparency/code/A9543TC?code_type=OTHER. Accessed .
“Y90 ibritumomab, rx (OTHER A9543TC) negotiated rates,” HANK Price Transparency, accessed , http://ppman.hank.ai/transparency/code/A9543TC?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital machine-readable files (45 CFR 180). See methodology.
Usually $247,108–$247,478 (25th–75th percentile) across 2 hospitals · 2 payers.
“Negotiated” is the hospital’s negotiated facility rate for this OTHER A9543TC — the consumer-grade median across the country. It covers the facility charge only; the surgeon’s and anesthesiologist’s fees are billed separately.
Per-month price trends are temporarily unavailable while we rebuild them on quality-filtered rates. The medians, percentiles, and per-hospital rates on this page are the quality-filtered figures.
Hospital rates (per row)
Showing consumer-grade rates only. Flagged / outlier filings (excluded from the medians above) are hidden — tick “Show flagged / outlier rates” to include them.
| Hospital | Payer | Plan | Negotiated rate | Gross | Cash | Observed | Source |
|---|---|---|---|---|---|---|---|
| FORT MEMORIAL HOSPITAL OutpatientFacility | Dean Health Plan | All Products | $246,923.66 | — | — | 2025-07-22 | MRF ↗ |
| COLUMBUS COMMUNITY HOSPITAL OutpatientFacility | DEAN HEALTH PLAN | ALL PRODUCTS | $247,662.86 | — | — | 2026-04-01 | MRF ↗ |